STAR — Strides Pharma Science Share News
0.000.00%
Last trade - 00:00- IN₹93.54bn
- IN₹107.43bn
- IN₹48.59bn
India's Strides Pharma to spin off contract development unit (updated)
India's Strides Pharma approves demerger of CDMO business into Stelis Biopharma
India's Strides Pharma up 8% after unit gets FDA nod
Brief: Strides Pharma Science Got Tentative USFDA Approval For Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate Tablets
India's Strides Pharma at near 2-year high on FDA nod for Dolutegravir
Brief: Strides Pharma Science Says Approved Acquisition Of 100% Shareholding In Strides Pharma Services
Brief: Strides Pharma Science Gets USFDA Approval For Mycophenolate Mofetil For Oral Suspension
Brief: India’s Strides Pharma Science June-Quarter Consol Net Loss Narrows
India's Strides Pharma down; Syngene to buy unit in slump sale
India's Strides Pharma falls on swinging to loss in Q4
Brief: India’S Strides Pharma Science Posts Loss For March-Quarter Vs Profit Year Ago
Brief: Strides Pharma Science Receives Establishment Inspection Report From US FDA For Puducherry Facility
Brief: Strides Pharma Science And Orbicular Enter Into A Strategic Partnership To Jointly Develop Nasal Sprays
Brief: Strides Pharma Science Strides Flagship Facility In Bangalore Receives USFDA Inspection Closure
Brief: India's Strides Pharma Science Dec-Quarter Consol Loss Narrows
Brief: Strides Pharma Science Says It Completed Inspection Carried Out By World Health Organization
Brief: Strides Pharma Science - Stelis Biopharma's Bengaluru Facility Receives EIR From USFDA
Brief: Strides Pharma Science Says Stelis Biopharma's CDMO Partner Gets Approval For Key ANDA From USFDA
India's HDFC Life, Strides Pharma see bullish breakout pattern